Somatostatin gene regulation

An overview

Richard Goodman, Robert P. Rehfuss, Menno Verhave, Roseann Ventimiglia, Malcolm J. Low

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The somatostatinergic system has proven to be one of the best models of neuropeptide biology. Originally characterized as a hypothalamic regulator of growth hormone secretion, somatostatin also regulates the secretion of several other pituitary, pancreatic, and gastrointestinal (GI) hormones including thyrotropin-stimulating hormone, insulin, glucagon, and gastrin. Disorders in somatostatin metabolism have been proposed to contribute to the pathogenesis of Alzheimer's disease, epilepsy, GI motility disorders, and diabetes. On a more basic level, studies of somatostatin action have integrated divergent concepts of intracellular signal transduction. Advances in the understanding of somatostatin biosynthesis have had an impact on areas outside the field of endocrinology by providing new concepts of eukaryotic gene regulation. This report focuses on the transriptional regulation of somatostatin gene expression. Two aspects of somatostatin gene transcription will be considered-regulated expression by second messengers and tissue-specific basal expression.

Original languageEnglish (US)
Pages (from-to)2-5
Number of pages4
JournalMetabolism
Volume39
Issue number9 SUPPL. 2
DOIs
StatePublished - 1990
Externally publishedYes

Fingerprint

Somatostatin
Genes
Pancreatic Hormones
Gastrointestinal Hormones
Gastrointestinal Motility
Pituitary Hormones
Endocrinology
Gastrins
Gene Expression Regulation
Second Messenger Systems
Thyrotropin
Neuropeptides
Glucagon
Growth Hormone
Epilepsy
Signal Transduction
Alzheimer Disease
Hormones
Insulin

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Goodman, R., Rehfuss, R. P., Verhave, M., Ventimiglia, R., & Low, M. J. (1990). Somatostatin gene regulation: An overview. Metabolism, 39(9 SUPPL. 2), 2-5. https://doi.org/10.1016/0026-0495(90)90197-K

Somatostatin gene regulation : An overview. / Goodman, Richard; Rehfuss, Robert P.; Verhave, Menno; Ventimiglia, Roseann; Low, Malcolm J.

In: Metabolism, Vol. 39, No. 9 SUPPL. 2, 1990, p. 2-5.

Research output: Contribution to journalArticle

Goodman, R, Rehfuss, RP, Verhave, M, Ventimiglia, R & Low, MJ 1990, 'Somatostatin gene regulation: An overview', Metabolism, vol. 39, no. 9 SUPPL. 2, pp. 2-5. https://doi.org/10.1016/0026-0495(90)90197-K
Goodman R, Rehfuss RP, Verhave M, Ventimiglia R, Low MJ. Somatostatin gene regulation: An overview. Metabolism. 1990;39(9 SUPPL. 2):2-5. https://doi.org/10.1016/0026-0495(90)90197-K
Goodman, Richard ; Rehfuss, Robert P. ; Verhave, Menno ; Ventimiglia, Roseann ; Low, Malcolm J. / Somatostatin gene regulation : An overview. In: Metabolism. 1990 ; Vol. 39, No. 9 SUPPL. 2. pp. 2-5.
@article{bcb61d561df343f98a85fbdb41fd0f3c,
title = "Somatostatin gene regulation: An overview",
abstract = "The somatostatinergic system has proven to be one of the best models of neuropeptide biology. Originally characterized as a hypothalamic regulator of growth hormone secretion, somatostatin also regulates the secretion of several other pituitary, pancreatic, and gastrointestinal (GI) hormones including thyrotropin-stimulating hormone, insulin, glucagon, and gastrin. Disorders in somatostatin metabolism have been proposed to contribute to the pathogenesis of Alzheimer's disease, epilepsy, GI motility disorders, and diabetes. On a more basic level, studies of somatostatin action have integrated divergent concepts of intracellular signal transduction. Advances in the understanding of somatostatin biosynthesis have had an impact on areas outside the field of endocrinology by providing new concepts of eukaryotic gene regulation. This report focuses on the transriptional regulation of somatostatin gene expression. Two aspects of somatostatin gene transcription will be considered-regulated expression by second messengers and tissue-specific basal expression.",
author = "Richard Goodman and Rehfuss, {Robert P.} and Menno Verhave and Roseann Ventimiglia and Low, {Malcolm J.}",
year = "1990",
doi = "10.1016/0026-0495(90)90197-K",
language = "English (US)",
volume = "39",
pages = "2--5",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "9 SUPPL. 2",

}

TY - JOUR

T1 - Somatostatin gene regulation

T2 - An overview

AU - Goodman, Richard

AU - Rehfuss, Robert P.

AU - Verhave, Menno

AU - Ventimiglia, Roseann

AU - Low, Malcolm J.

PY - 1990

Y1 - 1990

N2 - The somatostatinergic system has proven to be one of the best models of neuropeptide biology. Originally characterized as a hypothalamic regulator of growth hormone secretion, somatostatin also regulates the secretion of several other pituitary, pancreatic, and gastrointestinal (GI) hormones including thyrotropin-stimulating hormone, insulin, glucagon, and gastrin. Disorders in somatostatin metabolism have been proposed to contribute to the pathogenesis of Alzheimer's disease, epilepsy, GI motility disorders, and diabetes. On a more basic level, studies of somatostatin action have integrated divergent concepts of intracellular signal transduction. Advances in the understanding of somatostatin biosynthesis have had an impact on areas outside the field of endocrinology by providing new concepts of eukaryotic gene regulation. This report focuses on the transriptional regulation of somatostatin gene expression. Two aspects of somatostatin gene transcription will be considered-regulated expression by second messengers and tissue-specific basal expression.

AB - The somatostatinergic system has proven to be one of the best models of neuropeptide biology. Originally characterized as a hypothalamic regulator of growth hormone secretion, somatostatin also regulates the secretion of several other pituitary, pancreatic, and gastrointestinal (GI) hormones including thyrotropin-stimulating hormone, insulin, glucagon, and gastrin. Disorders in somatostatin metabolism have been proposed to contribute to the pathogenesis of Alzheimer's disease, epilepsy, GI motility disorders, and diabetes. On a more basic level, studies of somatostatin action have integrated divergent concepts of intracellular signal transduction. Advances in the understanding of somatostatin biosynthesis have had an impact on areas outside the field of endocrinology by providing new concepts of eukaryotic gene regulation. This report focuses on the transriptional regulation of somatostatin gene expression. Two aspects of somatostatin gene transcription will be considered-regulated expression by second messengers and tissue-specific basal expression.

UR - http://www.scopus.com/inward/record.url?scp=0025140993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025140993&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(90)90197-K

DO - 10.1016/0026-0495(90)90197-K

M3 - Article

VL - 39

SP - 2

EP - 5

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 9 SUPPL. 2

ER -